-
Product Insights
Severe Acute Respiratory Syndrome (SARS) - Drugs In Development, 2024
Empower your strategies with our Severe Acute Respiratory Syndrome (SARS) – Drugs In Development, 2024 report and make more profitable business decisions. Severe acute respiratory syndrome (SARS) is a serious, potentially life-threatening viral infection caused by virus from the Coronaviridae family. Symptoms include cough, chills and shaking, headache, muscle aches, diarrhea, dizziness, nausea, and vomiting. Risk factors include gene variation in the immune system and close contact with someone who has SARS. The Severe Acute Respiratory Syndrome (SARS) drugs in development...
-
Product Insights
Avian Influenza - Drugs In Development, 2024
Empower your strategies with our Avian Influenza – Drugs In Development, 2024 report and make more profitable business decisions. Avian influenza, commonly referred to as bird flu, is a viral infection that primarily affects birds, especially poultry such as chickens and turkeys. Various strains of avian influenza viruses exist, some of which can cause severe illness in birds and, in certain cases, pose a risk to human health. Avian influenza viruses belong to the influenza A virus family and are classified...
-
Product Insights
Pertussis (Whooping Cough) - Drugs In Development, 2024
Empower your strategies with our Pertussis (Whooping Cough) – Drugs In Development, 2024 report and make more profitable business decisions. Pertussis, also known as whooping cough, is a highly contagious respiratory disease. It is caused by the bacterium Bordetella pertussis. Symptoms include runny nose, nasal congestion, sneezing, red watery eyes, and dry cough. Treatment includes antibiotics. The Pertussis (Whooping Cough) drugs in development market research report provide comprehensive information on the therapeutics under development for Pertussis (Whooping Cough), complete with analysis...
-
Product Insights
Chikungunya Fever - Drugs In Development, 2024
Empower your strategies with our Chikungunya Fever – Drugs In Development, 2024 report and make more profitable business decisions. Chikungunya is a viral disease transmitted to humans by the bite of infected Aedes aegypti mosquitoes. Chikungunya virus (CHIKV) is a member of the genus Alpha virus, in the family Togaviridae. Symptoms of Chikungunya includes debilitating arthralgia (joint pain), swelling of joints, stiffness of joints, myalgia (muscular pain), headache, fatigue (weakness), nausea, vomiting, and rash and fever. Treatment includes use of non-steroidal...
-
Product Insights
Herpes Zoster (Shingles) - Drugs In Development, 2024
Empower your strategies with our Herpes Zoster (Shingles) – Drugs In Development, 2024 report and make more profitable business decisions. Shingles (herpes zoster) is a painful, blistering skin rash. It is caused by the varicella-zoster virus. Symptoms may include fever and chills, headache, joint pain, and swollen glands. The predisposing factors include age and weakened immune system. Treatment includes antihistamines and pain relievers. The Herpes Zoster (Shingles) drugs in development market research report provide comprehensive information on the therapeutics under development...
-
Product Insights
Lymphocryptovirus Infections - Drugs In Development, 2024
Empower your strategies with our Lymphocryptovirus Infections – Drugs In Development, 2024 report and make more profitable business decisions. Lymphocryptovirus infections are caused by a genus of herpesviruses that infect humans and other primates. The most well-known lymphocryptovirus is the Epstein-Barr virus (EBV), which can cause mononucleosis, lymphoma, and nasopharyngeal carcinoma in humans. Lymphocryptovirus infections are usually latent, meaning that the virus remains dormant in the host cells until it is reactivated by stress or immune suppression. Lymphocryptovirus infections can be...
-
Product Insights
Marburgvirus Infections (Marburg Hemorrhagic Fever) - Drugs In Development, 2024
Empower your strategies with our Marburgvirus Infections (Marburg Hemorrhagic Fever) – Drugs In Development, 2024 report and make more profitable business decisions. Marburg hemorrhagic fever is a rare, acute infectious disease that affects both human and nonhuman primates. Symptoms include fever, headache, chills, weakness, diarrhea, stomach pain, and weight loss. The Marburgvirus Infections (Marburg Hemorrhagic Fever) drugs in development market research report provide comprehensive information on the therapeutics under development for Marburgvirus Infections (Marburg Hemorrhagic Fever), complete with analysis by stage...
-
Product Insights
Aspergillosis - Drugs In Development, 2024
Empower your strategies with our Aspergillosis – Drugs In Development, 2024 report and make more profitable business decisions. Aspergillosis is an infection or allergic response due to the Aspergillus fungus. Symptoms include cough, fever, headaches, general ill feeling (malaise), weight loss, and chest pain. The predisposing factors include weakened immune system, low white blood cell level, asthma, and long-term corticosteroid therapy. Treatment includes oral corticosteroids, antifungals, and surgery. The Aspergillosis drugs in development market research report provide comprehensive information on the...
-
Product Insights
Genital Herpes - Drugs In Development, 2024
Empower your strategies with our Genital Herpes – Drugs In Development, 2024 report and make more profitable business decisions. Genital herpes is a common sexually transmitted infection that affects both men and women. Genital herpes is caused by the herpes simplex virus (HSV). Symptoms include decreased appetite; fever; general sick feeling (malaise); muscle aches in the lower back, buttocks, thighs, or knees; and swollen and tender lymph nodes in the groin during an outbreak. Treatment includes antiviral medications. The Genital Herpes...